Former Hershey Resident Charged Federally With Adulteration Of Medical Devices
The United States Attorney's Office for the Middle District of Pennsylvania announced the filing of a Criminal Information yesterday charging William Joseph Zinnanti, age 42, of Mountain View,...
People with paralysis control robotic arms using brain-computer interface
People with paralysis control robotic arms using brain-computer interface PROVIDENCE, R.I. [Brown University] — On April 12, 2011, nearly 15 years after she became paralyzed and unable to...
Dehaier Medical launches U.S. Subsidiary to fuel further global expansion
Dehaier Medical Establishes its Wholly-owned U.S. Subsidiary to Further International Expansion, Including Seeking FDA Approval of its Homecare Product BEIJING, May 16, 2012...
Mitralign grabs $35M Series D cash to advance mitral valve repair device
Cardiac device company Mitralign attracted $35 million in new Series D financing. The Tewksbury, MA, company plans to use the investment infusion with its eyes toward European testing and commercial launch for its catheter-based mitral valve repair system.
Mitralign Raises $35 Million Series D Financing
Mitralign Raises $35 Million Series D Financing TEWKSBURY, Mass.--(BUSINESS WIRE)--Mitralign, Inc., a cardiac device company leading the way in percutaneous mitral valve repair, today announced the...
Devicemaker CryoLife coughs up $17M-plus for Hemosphere
CryoLife ($CRY) will pay an initial $17 million in cash for Hemosphere so it can grab its HeRO graft to treat end-stage renal disease.
FDA expands use for FilmArray Respiratory Panel
FDA expands use for FilmArray Respiratory Panel Test is first to detect viral, bacterial causes of respiratory infection from single sample The U.S. Food and Drug Administration today expanded the...
NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio Company sees potential for Thin-Film Nitinol in next-generation flow-diverting stents for treating intracranial aneurysms...
CryoLife to Acquire Hemosphere
CryoLife to Acquire Hemosphere HeRO® Graft is Standard of Care to Establish Permanent Access for Catheter Dependent Hemodialysis Patients Leverages CryoLife's Cardiovascular Sales Force to...
NeuroSigma buys patents that advance TFN stents
NSVascular, a subsidiary of NeuroSigma, has picked up a portfolio of patents that will help it develop its technology for more easily treating intracranial aneurysms.
Latest Commentary